[HTLV-I and genetic polymorphisms other than HLA].
Nishimura
M
M
Department of Neurology, Utano National Hospital.
Matsuoka
M
M
D000069594:Abatacept; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000502:physiology; D060908:CTLA-4 Antigen; D015815:Cell Adhesion Molecules / Q000235:genetics; D018925:Chemokines / Q000235:genetics; D016207:Cytokines / Q000235:genetics; D016356:Gene Products, tax / Q000502:physiology; D016147:Genes, Tumor Suppressor; D006680:HLA Antigens / Q000235:genetics; D015490:HTLV-I Infections / Q000235:genetics / Q000821:virology; D015368:Human T-lymphotropic virus 1 / Q000235:genetics*; D006801:Humans; D007113:Immunity, Innate; D018796:Immunoconjugates; D019001:Nitric Oxide Synthase / Q000502:physiology; D009928:Organ Specificity / Q000235:genetics; D011110:Polymorphism, Genetic
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines; D016356:Gene Products, tax; D006680:HLA Antigens; D018796:Immunoconjugates; D000069594:Abatacept; D019001:Nitric Oxide Synthase